Anna Morelli

1.1k total citations
19 papers, 153 citations indexed

About

Anna Morelli is a scholar working on Oncology, Molecular Biology and Hematology. According to data from OpenAlex, Anna Morelli has authored 19 papers receiving a total of 153 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 5 papers in Molecular Biology and 4 papers in Hematology. Recurrent topics in Anna Morelli's work include Lung Cancer Research Studies (5 papers), Multiple Myeloma Research and Treatments (4 papers) and Ancient Mediterranean Archaeology and History (2 papers). Anna Morelli is often cited by papers focused on Lung Cancer Research Studies (5 papers), Multiple Myeloma Research and Treatments (4 papers) and Ancient Mediterranean Archaeology and History (2 papers). Anna Morelli collaborates with scholars based in Italy. Anna Morelli's co-authors include Cinzia Solinas, Silvia Novello, Rita Chiari, Fausto Petrelli, Lorenza Landi, Gianluca Spitaleri, Francesco Facchinetti, Federico Cappuzzo, Diego Cortinovis and Laura Bonanno and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Clinical Chemistry.

In The Last Decade

Anna Morelli

16 papers receiving 148 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Morelli Italy 7 61 56 39 31 28 19 153
Yana Novis Brazil 6 27 0.4× 78 1.4× 28 0.7× 21 0.7× 20 0.7× 13 171
Hirohisa Kano Japan 9 114 1.9× 101 1.8× 9 0.2× 45 1.5× 20 0.7× 29 238
Phoenix Bell United States 8 29 0.5× 47 0.8× 17 0.4× 14 0.5× 14 0.5× 20 150
R. Rajan Canada 6 42 0.7× 21 0.4× 70 1.8× 14 0.5× 58 2.1× 13 171
Jan Hudeček Slovakia 7 81 1.3× 21 0.4× 18 0.5× 19 0.6× 12 0.4× 14 190
Syed A. Abutalib United States 5 19 0.3× 29 0.5× 67 1.7× 48 1.5× 47 1.7× 11 165
Antonella Bruzzese Italy 6 27 0.4× 33 0.6× 13 0.3× 47 1.5× 13 0.5× 34 158
Yin Liu China 8 34 0.6× 57 1.0× 7 0.2× 33 1.1× 57 2.0× 32 185
Anna D’Agostino Italy 9 131 2.1× 22 0.4× 13 0.3× 26 0.8× 109 3.9× 17 244
V. Filipazzi Italy 8 116 1.9× 139 2.5× 14 0.4× 24 0.8× 6 0.2× 19 195

Countries citing papers authored by Anna Morelli

Since Specialization
Citations

This map shows the geographic impact of Anna Morelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Morelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Morelli more than expected).

Fields of papers citing papers by Anna Morelli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Morelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Morelli. The network helps show where Anna Morelli may publish in the future.

Co-authorship network of co-authors of Anna Morelli

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Morelli. A scholar is included among the top collaborators of Anna Morelli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Morelli. Anna Morelli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Bertaglia, Valentina, Fausto Petrelli, Lorenzo Dottorini, et al.. (2024). Chemotherapy plus immunotherapy as first line combination in older patients with extensive stage small cell lung cancer: A systematic review and meta-analysis. Seminars in Oncology. 52(1). 14–18. 4 indexed citations
2.
Bertaglia, Valentina, Anna Morelli, Cinzia Solinas, et al.. (2023). Infections in lung cancer patients undergoing immunotherapy and targeted therapy: An overview on the current scenario. Critical Reviews in Oncology/Hematology. 184. 103954–103954. 11 indexed citations
3.
Pilotto, Sara, Francesco Agustoni, Anna Morelli, et al.. (2022). Nutritional support in lung cancer: Time to combine immunonutrition with immunotherapy?. Nutrition. 98. 111637–111637. 4 indexed citations
4.
Petrelli, Fausto, Anna Morelli, Andrea Luciani, Antonio Ghidini, & Cinzia Solinas. (2021). Risk of Infection with Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysis. Targeted Oncology. 16(5). 553–568. 19 indexed citations
6.
Rocchi, Marco, et al.. (2020). Adherence to and effectiveness of lenalidomide after 1 year of treatment in a real world setting. Journal of Oncology Pharmacy Practice. 28(1). 24–30. 4 indexed citations
7.
Chiari, Rita, Biagio Ricciuti, Lorenza Landi, et al.. (2019). ROS1-rearranged Non–small-cell Lung Cancer is Associated With a High Rate of Venous Thromboembolism: Analysis From a Phase II, Prospective, Multicenter, Two-arms Trial (METROS). Clinical Lung Cancer. 21(1). 15–20. 62 indexed citations
8.
Morelli, Anna, et al.. (2018). Management of Leptomeningeal Metastases in Non-oncogene Addicted Non-small Cell Lung Cancer. Frontiers in Oncology. 8. 278–278. 13 indexed citations
9.
Morelli, Anna, Leonardo S. Mattos, Giovanni Cordima, et al.. (2018). Towards deformable registration for AR in nephrectomy. Virtual Community of Pathological Anatomy (University of Castilla La Mancha). 1–2. 1 indexed citations
10.
Guadagni, Fiorella, Silvia Riondino, Vincenzo Formica, et al.. (2017). Clinical significance of glycemic parameters on venous thromboembolism risk prediction in gastrointestinal cancer. World Journal of Gastroenterology. 23(28). 5187–5187. 9 indexed citations
11.
Nakawala, Hirenkumar, et al.. (2017). Inductive Learning of the Surgical Workflow Model through Video Annotations. Virtual Community of Pathological Anatomy (University of Castilla La Mancha). 292–297. 4 indexed citations
12.
Torti, Lorenza, Stefano Pulini, Anna Morelli, Francesco Bacci, & Paolo Di Bartolomeo. (2016). New Myeloma Diagnostic Criteria: To Treat or Not to Treat? Monocentric Experience of 220 Newly Multiple Myeloma Diagnosed Patients Retrospectively Analyzed. Blood. 128(22). 5629–5629. 1 indexed citations
13.
Torti, Lorenza, Stefano Pulini, Anna Morelli, Francesco Bacci, & Paolo Di Bartolomeo. (2015). Visceral leishmaniasis in relapsed and overtreated multiple myeloma in the era of high dose and “novel agent” therapy. International Journal of Hematology. 102(4). 391–393. 2 indexed citations
14.
Morelli, Anna, et al.. (2014). Oro sacro. Aspetti religiosi ed economici da Atene a Bisanzio. 1–272.
15.
Gacci, Mauro, Gianni Vittori, Andrea Minervini, et al.. (2013). Changes in sex hormone levels after radical prostatectomy: Results of a longitudinal cohort study. Oncology Letters. 6(2). 529–533. 8 indexed citations
16.
Morelli, Anna, et al.. (2012). Luoghi, artigiani e modi di produzione nell'oreficeria antica. 1–385.
17.
Pulini, Stefano, et al.. (2009). Extramedullary Relapses After Stem Cell Transplantation in Multiple Myeloma.. Blood. 114(22). 4959–4959. 1 indexed citations
18.
Morelli, Anna, et al.. (2001). Proapoptotic plasma membrane pore: P2X7 receptor. Drug Development Research. 52(4). 571–578. 1 indexed citations
19.
Franzini, Carlo, et al.. (1991). Use of a synthetic soluble bilirubin derivative to assess interference in creatinine measurements. Clinical Chemistry. 37(2). 236–238. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026